Autoimmune Disorders
Inflammatory Bowel Disease II: Crohn's Disease
T Cell Types and Functions
Inflammatory Bowel Disease I: Ulcerative Colitis
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 9, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
M-L Frémond1, L Berteloot2, A Hadchouel3
1Unité d'immuno-hématologie et rhumatologie pédiatriques, hôpital Necker-Enfants-Malades, AP-HP, centre université de Paris-Cité, 149, rue de Sèvres, 75015 Paris, France; Institut imagine, laboratoire de neurogénétique et neuroinflammation, université de Paris-Cité, 24, boulevard du Montparnasse, 75015 Paris, France.
Genetic autoinflammatory diseases increasingly affect the lungs, leading to conditions like pulmonary fibrosis. Molecular diagnostics and targeted therapies, such as JAK inhibitors and methionine supplementation, offer new hope for these rare lung diseases.
Area of Science:
Context:
Purpose:
Summary:
Impact: